These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33146377)

  • 1. Racial and Ethnic Differences in Multigene Hereditary Cancer Panel Test Results for Women With Breast Cancer.
    Yadav S; LaDuca H; Polley EC; Hu C; Niguidula N; Shimelis H; Lilyquist J; Na J; Lee KY; Gutierrez S; Yussuf A; Hart SN; Davis BT; Chao EC; Pesaran T; Goldgar DE; Dolinsky JS; Couch FJ
    J Natl Cancer Inst; 2021 Oct; 113(10):1429-1433. PubMed ID: 33146377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial and ethnic variation in multigene panel testing in a cohort of BRCA1/2-negative individuals who had genetic testing in a large urban comprehensive cancer center.
    Tatineni S; Tarockoff M; Abdallah N; Purrington KS; Assad H; Reagle R; Petrucelli N; Simon MS
    Cancer Med; 2022 Mar; 11(6):1465-1473. PubMed ID: 35040284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the Breast.
    Yadav S; Hu C; Nathanson KL; Weitzel JN; Goldgar DE; Kraft P; Gnanaolivu RD; Na J; Huang H; Boddicker NJ; Larson N; Gao C; Yao S; Weinberg C; Vachon CM; Trentham-Dietz A; Taylor JA; Sandler DR; Patel A; Palmer JR; Olson JE; Neuhausen S; Martinez E; Lindstrom S; Lacey JV; Kurian AW; John EM; Haiman C; Bernstein L; Auer PW; Anton-Culver H; Ambrosone CB; Karam R; Chao E; Yussuf A; Pesaran T; Dolinsky JS; Hart SN; LaDuca H; Polley EC; Domchek SM; Couch FJ
    J Clin Oncol; 2021 Dec; 39(35):3918-3926. PubMed ID: 34672684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer.
    Weitzel JN; Neuhausen SL; Adamson A; Tao S; Ricker C; Maoz A; Rosenblatt M; Nehoray B; Sand S; Steele L; Unzeitig G; Feldman N; Blanco AM; Hu D; Huntsman S; Castillo D; Haiman C; Slavin T; Ziv E
    Cancer; 2019 Aug; 125(16):2829-2836. PubMed ID: 31206626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial and Ethnic Disparities in Genetic Testing at a Hereditary Breast and Ovarian Cancer Center.
    Chapman-Davis E; Zhou ZN; Fields JC; Frey MK; Jordan B; Sapra KJ; Chatterjee-Paer S; Carlson AD; Holcomb KM
    J Gen Intern Med; 2021 Jan; 36(1):35-42. PubMed ID: 32720237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Male breast cancer risk associated with pathogenic variants in genes other than BRCA1/2: an Italian case-control study.
    Bucalo A; Conti G; Valentini V; Capalbo C; Bruselles A; Tartaglia M; Bonanni B; Calistri D; Coppa A; Cortesi L; Giannini G; Gismondi V; Manoukian S; Manzella L; Montagna M; Peterlongo P; Radice P; Russo A; Tibiletti MG; Turchetti D; Viel A; Zanna I; Palli D; Silvestri V; Ottini L
    Eur J Cancer; 2023 Jul; 188():183-191. PubMed ID: 37262986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Breast Cancer Among Carriers of Pathogenic Variants in Breast Cancer Predisposition Genes Varies by Polygenic Risk Score.
    Gao C; Polley EC; Hart SN; Huang H; Hu C; Gnanaolivu R; Lilyquist J; Boddicker NJ; Na J; Ambrosone CB; Auer PL; Bernstein L; Burnside ES; Eliassen AH; Gaudet MM; Haiman C; Hunter DJ; Jacobs EJ; John EM; Lindström S; Ma H; Neuhausen SL; Newcomb PA; O'Brien KM; Olson JE; Ong IM; Patel AV; Palmer JR; Sandler DP; Tamimi R; Taylor JA; Teras LR; Trentham-Dietz A; Vachon CM; Weinberg CR; Yao S; Weitzel JN; Goldgar DE; Domchek SM; Nathanson KL; Couch FJ; Kraft P
    J Clin Oncol; 2021 Aug; 39(23):2564-2573. PubMed ID: 34101481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of a Polygenic Risk Score With Breast Cancer Among Women Carriers of High- and Moderate-Risk Breast Cancer Genes.
    Gallagher S; Hughes E; Wagner S; Tshiaba P; Rosenthal E; Roa BB; Kurian AW; Domchek SM; Garber J; Lancaster J; Weitzel JN; Gutin A; Lanchbury JS; Robson M
    JAMA Netw Open; 2020 Jul; 3(7):e208501. PubMed ID: 32609350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes.
    Buys SS; Sandbach JF; Gammon A; Patel G; Kidd J; Brown KL; Sharma L; Saam J; Lancaster J; Daly MB
    Cancer; 2017 May; 123(10):1721-1730. PubMed ID: 28085182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the Prevalence of Pathogenic Variants in Cancer Susceptibility Genes in Black Women and Non-Hispanic White Women With Breast Cancer in the United States.
    Domchek SM; Yao S; Chen F; Hu C; Hart SN; Goldgar DE; Nathanson KL; Ambrosone CB; Haiman CA; Couch FJ; Polley EC; Palmer JR;
    JAMA Oncol; 2021 Jul; 7(7):1045-1050. PubMed ID: 34042955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial and ethnic variation in BRCA1 and BRCA2 genetic test results among individuals referred for genetic counseling at a large urban comprehensive cancer center.
    Abdallah N; Purrington KS; Tatineni S; Assad H; Petrucelli N; Simon MS
    Cancer Causes Control; 2023 Feb; 34(2):141-149. PubMed ID: 36370215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline pathogenic variants in Mexican patients with hereditary triple-negative breast cancer.
    Chavarri-Guerra Y; Villarreal-Garza C; Ferrigno AS; Mohar A; Aguilar D; Alvarez-Gomez RM; Gallardo-Alvarado L; Del Toro-Valero A; Quintero-Beulo G; Gutierrez-Delgado F; Rodriguez-Olivares JL; Ochoa-Chavez MF; Gutierrez-Seymour G; Castillo D; Herzog J; Weitzel JN
    Salud Publica Mex; 2022 Feb; 64(1):41-48. PubMed ID: 35438911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups.
    John EM; Miron A; Gong G; Phipps AI; Felberg A; Li FP; West DW; Whittemore AS
    JAMA; 2007 Dec; 298(24):2869-76. PubMed ID: 18159056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of ATM founder mutation in BRCA-negative breast cancer patients of Arab ethnicity.
    Bu R; Siraj AK; Al-Rasheed M; Iqbal K; Azam S; Qadri Z; Haqawi W; Tulbah A; Al-Dayel F; Almalik O; Al-Kuraya KS
    Sci Rep; 2023 Nov; 13(1):20924. PubMed ID: 38017116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Summary of
    Suszynska M; Kozlowski P
    Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32679805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High risk of breast cancer in women with biallelic pathogenic variants in CHEK2.
    Rainville I; Hatcher S; Rosenthal E; Larson K; Bernhisel R; Meek S; Gorringe H; Mundt E; Manley S
    Breast Cancer Res Treat; 2020 Apr; 180(2):503-509. PubMed ID: 31993860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary cancer testing in a diverse sample across three breast imaging centers.
    Westbrook L; Miltenburg D; Souter V; Maisenbacher MK; Howard KL; Sha Y; Yavari M; Kypraios N; Rodriguez A; Weitzel JN
    Breast Cancer Res Treat; 2024 Jan; 203(2):365-372. PubMed ID: 37861889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Burden of Breast Cancer Predisposition Variants Across The Age Spectrum Among 10 000 Patients.
    Chavarri-Guerra Y; Hendricks CB; Brown S; Marcum C; Hander M; Segota ZE; Hake C; Sand S; Slavin TP; Hurria A; Soto-Perez-de-Celis E; Nehoray B; Blankstein KB; Blazer KR; Weitzel JN;
    J Am Geriatr Soc; 2019 May; 67(5):884-888. PubMed ID: 31012959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception.
    Bychkovsky BL; Lo MT; Yussuf A; Horton C; Hemyari P; LaDuca H; Garber JE; Scheib R; Rana HQ
    Breast Cancer Res Treat; 2023 Jul; 200(1):63-72. PubMed ID: 36856935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between age at breast cancer diagnosis and prevalence of pathogenic variants.
    Daly MB; Rosenthal E; Cummings S; Bernhisel R; Kidd J; Hughes E; Gutin A; Meek S; Slavin TP; Kurian AW
    Breast Cancer Res Treat; 2023 Jun; 199(3):617-626. PubMed ID: 37084156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.